Guggenheim Capital’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-1,775
Closed -$214K – 1950
2023
Q3
$214K Buy
1,775
+85
+5% +$11.9K ﹤0.01% 1740
2023
Q2
$283K Buy
1,690
+210
+14% +$43.6K ﹤0.01% 1681
2023
Q1
$374K Sell
1,480
-947
-39% -$219K ﹤0.01% 1609
2022
Q4
$442K Buy
2,427
+504
+26% +$109K ﹤0.01% 1540
2022
Q3
$453K Sell
1,923
-144
-7% -$36.4K ﹤0.01% 1518
2022
Q2
$532K Buy
2,067
+413
+25% +$111K ﹤0.01% 1556
2022
Q1
$559K Buy
1,654
+24
+1% +$7.92K ﹤0.01% 1650
2021
Q4
$788K Buy
+1,630
New +$840K ﹤0.01% 1478

Other funds holding SKIN

Guggenheim Capital's SKIN Position: Q4 2023 in Review

Guggenheim Capital sold out of SkinHealth Systems (SKIN) in Q4 2023, closing a stake of 1,775 shares — an estimated $214K sold.

Guggenheim Capital first reported a position in SKIN in Q4 2021 and held it in 8 quarters. The position peaked at $788K in Q4 2021. 130 funds tracked by Wall St. Rank hold SKIN as of Q4 2023.

  • Guggenheim Capital reported no remaining SkinHealth Systems position as of Q4 2023 after selling out during the quarter.
  • Guggenheim Capital sold 1,775 SkinHealth Systems shares in Q4 2023, an estimated $214K.
  • Guggenheim Capital first reported a position in SkinHealth Systems in Q4 2021 and held it in 8 quarters.
  • Guggenheim Capital's SkinHealth Systems position peaked at $788K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2023.

Based on Guggenheim Capital's 13F filing for Q4 2023, filed 14 Feb 2024.